[Form 4] Kindly MD, Inc. Insider Trading Activity
Tyler Matthew Evans, identified as Chief Investment Officer and a director of Kindly MD, Inc. (NAKA), reported on Form 4 that on 08/14/2025 he acquired 2,232,114 shares of the issuer’s common stock at a reported price of $0, increasing his total beneficial ownership to 2,410,685 shares. The filing is signed on 08/22/2025. The form shows a non-derivative acquisition only and provides no additional explanatory detail about the mechanics or consideration for the transaction.
- Insider acquisition disclosed: Reporting person acquired 2,232,114 common shares, increasing transparency about insider ownership.
- None.
Insights
TL;DR: Insider acquired a large block of company stock; filing reports quantity but not economic consideration.
The Form 4 discloses a non-derivative acquisition of 2,232,114 common shares by Tyler Evans, bringing his total to 2,410,685 shares. The transaction date is 08/14/2025 and the report shows a price of $0, with no derivative activity disclosed. From a securities-transaction perspective, the report documents a material shareholding change by a senior officer and director. However, the filing lacks contextual details on how the acquisition was executed or funded, which limits assessment of economic impact.
TL;DR: Officer/director reported sizable share acquisition; the $0 price notation needs clarification in follow-up filings.
As Chief Investment Officer and director, Evans’ increased stake to 2,410,685 shares is notable for ownership disclosure and governance transparency. The Form 4 contains the required signature and dates but does not explain the $0 price or indicate a Rule 10b5-1 plan; absence of that detail means investors must rely solely on the disclosed numbers. This filing satisfies the basic Section 16 reporting obligation but invites questions about the transaction’s nature that are not answered in this record.